XML 19 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect Period of Adoption Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect Period of Adoption Adjustment
Total Stockholders' Equity
Total Stockholders' Equity
Cumulative Effect Period of Adoption Adjustment
Non-controlling Interest-Operating Partnership
Balance at Dec. 31, 2018 $ 1,415,059   $ 1,187 $ 1,807,202 $ (393,330)        
Balance (in shares) at Dec. 31, 2018     118,674            
Net income 49,340       49,340        
Retirement of common stock (3,070)   $ (1) (3,069)          
Retirement of common stock (in shares)     (143)            
Dividends declared on common stock (52,994)       (52,994)        
Restricted stock compensation, net of forfeitures 3,812     3,812          
Restricted stock grants     $ 5 (5)          
Restricted stock grants (in shares)     521            
Stock options exercised 207     207          
Stock options exercised (in shares)     16            
Balance at Mar. 31, 2019 1,382,414 $ (29,940) $ 1,191 1,808,147 (426,924) $ (29,940)      
Balance (in shares) at Mar. 31, 2019     119,068            
Balance at Dec. 31, 2018 1,415,059   $ 1,187 1,807,202 (393,330)        
Balance (in shares) at Dec. 31, 2018     118,674            
Net income 146,912                
Balance at Sep. 30, 2019 1,383,201   $ 1,191 1,817,258 (435,248)        
Balance (in shares) at Sep. 30, 2019     119,096            
Balance at Mar. 31, 2019 1,382,414 (29,940) $ 1,191 1,808,147 (426,924) (29,940)      
Balance (in shares) at Mar. 31, 2019     119,068            
Net income 48,578       48,578        
Retirement of common stock (460)     (460)          
Retirement of common stock (in shares)     (21)            
Dividends declared on common stock (52,865)       (52,865)        
Restricted stock compensation, net of forfeitures 4,256     4,256          
Restricted stock grants (in shares)     3            
Stock options exercised 668     668          
Stock options exercised (in shares)     46            
Balance at Jun. 30, 2019 1,382,591   $ 1,191 1,812,611 (431,211)        
Balance (in shares) at Jun. 30, 2019     119,096            
Net income 48,994       48,994        
Dividends declared on common stock (53,031)       (53,031)        
Restricted stock compensation, net of forfeitures 4,647     4,647          
Balance at Sep. 30, 2019 1,383,201   $ 1,191 1,817,258 (435,248)        
Balance (in shares) at Sep. 30, 2019     119,096            
Balance at Dec. 31, 2019 1,376,749   $ 1,191 1,821,810 (446,252)   $ 1,376,749    
Balance (in shares) at Dec. 31, 2019     119,096            
Net income 33,238       32,057   32,057   $ 1,181
Retirement of common stock (3,560)   $ (2) (3,558)     (3,560)    
Retirement of common stock (in shares)     (207)            
Dividends declared on common stock (53,415)       (53,415)   (53,415)    
Restricted stock compensation, net of forfeitures 4,610     4,610     4,610    
Restricted stock grants     $ 7 (7)          
Restricted stock grants (in shares)     740            
Balance at Mar. 31, 2020 1,378,676 (1,036) $ 1,196 1,822,855 (468,646) (1,036) 1,355,405 $ (1,036) 23,271
Contributions to operating partnership 23,271               23,271
Distributions to non-controlling interest (1,181)               (1,181)
Balance (in shares) at Mar. 31, 2020     119,629            
Balance at Dec. 31, 2019 1,376,749   $ 1,191 1,821,810 (446,252)   1,376,749    
Balance (in shares) at Dec. 31, 2019     119,096            
Net income 82,141                
Balance at Sep. 30, 2020 1,435,992   $ 1,196 1,831,241 (419,716)   1,412,721   23,271
Balance (in shares) at Sep. 30, 2020     119,634            
Balance at Mar. 31, 2020 1,378,676 $ (1,036) $ 1,196 1,822,855 (468,646) $ (1,036) 1,355,405 $ (1,036) 23,271
Balance (in shares) at Mar. 31, 2020     119,629            
Net income 22,186       22,186   22,186    
Restricted stock compensation, net of forfeitures 4,319     4,319     4,319    
Restricted stock grants (in shares)     2            
Balance at Jun. 30, 2020 1,405,181   $ 1,196 1,827,174 (446,460)   1,381,910   23,271
Balance (in shares) at Jun. 30, 2020     119,631            
Net income 26,717       26,717   26,717    
Retirement of common stock (15)     (15)     (15)    
Retirement of common stock (in shares)     (2)            
Reductions in dividends on RSUs 27       27   27    
Restricted stock compensation, net of forfeitures 4,082     4,082     4,082    
Restricted stock grants (in shares)     5            
Balance at Sep. 30, 2020 $ 1,435,992   $ 1,196 $ 1,831,241 $ (419,716)   $ 1,412,721   $ 23,271
Balance (in shares) at Sep. 30, 2020     119,634